Our Global Life Sciences M&A team were invited by Financier Worldwide, a leading, widely respected information source covering corporate finance and board-level business issues to provide their views on the life sciences M&A market for the upcoming November issue. The topics covered in the Q&A include deal appetite, regulatory changes, FDI, managing transactional risk, pre and post deal strategies, and the future of the market. 

***************

This article was first published by Financier Worldwide Ltd 
©2023 Financier Worldwide Ltd. All rights reserved. 
Permission to use this reprint has been granted by the publisher.

***************